Director Ronald J. Daniels sold 61,031 shares of BBIO at $63.72 for $3.9M, retaining 16,991 shares (-78.2% of holdings).
Ronald J. Daniels divested the majority of his BBIO position, reducing holdings from 78,022 shares to 16,991 shares via a single $3.9M sale at $63.72 per share. This large-scale reduction occurred while the stock sits 7.2% below its 52-week high of $66.62 and near recent multi-year trading levels, within a context of exceptional revenue growth (annual growth +2285.3%) but persistent unprofitability (net income of $-184.9M in the latest full fiscal year). The near-complete liquidation of a director's position warrants investor scrutiny of the factors driving such a substantial departure from the stock.